Fighting resistance in Cancer
Oncology
Beyond the known, Sightera's patient-centric drug discovery approach
An innovative targeted therapy against resistant types of lung cancer
AbTx
Lilly Moran, , 0Smaller ADC formats generated by enzymatic conjugation could make a difference for solid tumors
Becoming the world leader of sustainable bioproduction of antibodies using microalgae
A New Hope for Poor-Prognosis Cancers with One-Day, Targeted Radiotherapy
What if viral remnants kept silent in our DNA held the key to overcoming the deadliest cancers?
Transforming immunotherapy to "off-the-shelf", safe, cost-efficient and scalable treatment for all










